Your session is about to expire
← Back to Search
Procedure
Shoulder Replacement Techniques for Arthritis
N/A
Waitlist Available
Led By Young W Kwon, MD, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient is indicated for shoulder joint replacement
Be older than 18 years old
Must not have
Significant injury to the brachial plexus
Significant deformity of the proximal humerus that requires a custom made implant or where osteotomy of the shaft and / or the tuberosity has to be considered.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up preoperatively
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the long-term outcomes of two different approaches to total shoulder replacement surgery.
Who is the study for?
This trial is for adults over 21 with arthritis needing shoulder replacement, who can survive at least 2 years post-surgery and commit to follow-up visits. It's not for those with prior shoulder replacements, brachial plexus injuries, inability to do long-term follow-ups, pregnant or lactating women, or significant shoulder deformities.
What is being tested?
The study compares two surgical techniques for total shoulder replacement: the traditional subscapularis release (TSR) and a newer rotator cuff sparing method. It aims to evaluate the long-term outcomes of each approach in patients randomized into two groups.
What are the potential side effects?
While specific side effects are not listed here, typical risks may include pain at the surgery site, infection risk from surgery, possible damage to nearby nerves or blood vessels during operation, and complications related to anesthesia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am recommended to have a shoulder joint replacement.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a serious injury to the nerves in my shoulder.
Select...
I need a custom implant for my upper arm bone due to its significant shape issue.
Select...
I have had joint replacement surgery in my affected shoulder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ preoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~preoperatively
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Functional Outcome
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TSR: rotator cuff sparingExperimental Treatment1 Intervention
Rotator cuff sparing technique TSR
Group II: TSR: traditional subscap releaseActive Control1 Intervention
TSR - traditional subscapularis release approach
Subscapularis tendon release technique TSR
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,415 Previous Clinical Trials
856,095 Total Patients Enrolled
17 Trials studying Osteoarthritis
4,005 Patients Enrolled for Osteoarthritis
Young W Kwon, MD, PhDPrincipal InvestigatorNYU Hospital for Joint Diseases
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am recommended to have a shoulder joint replacement.I need a custom implant for my upper arm bone due to its significant shape issue.I have a serious injury to the nerves in my shoulder.I am willing to follow all visit requirements before and after surgery.I am 21 years old or older.Your shoulder joint has severe damage that affects the position of the humerus bone.I have had joint replacement surgery in my affected shoulder.You are expected to live for at least 2 years after the surgery.
Research Study Groups:
This trial has the following groups:- Group 1: TSR: traditional subscap release
- Group 2: TSR: rotator cuff sparing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.